Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017

Matthew Harrison Downgraded (BLUE) to Sell on, Oct 2nd, 2017

Matthew Harrison of Morgan Stanley, Downgraded "bluebird bio, Inc." (BLUE) to Sell on, Oct 2nd, 2017.

Matthew has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Initiated at Hold and Held Target at $102 on, Thursday, August 17th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017
  • Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Gena Wang of "Barclays" Initiated at Buy and Held Target at $151 on, Thursday, September 7th, 2017
  • Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017